Acute Respiratory Distress Syndrome clinical trials at UCLA
2 in progress, 1 open to eligible people
ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)
open to eligible people ages up to 20 years
ASCEND researchers are partnering with families of children who receive extracorporeal membrane oxygenation (ECMO) after a sudden failure of breathing named pediatric acute respiratory distress syndrome (PARDS). ECMO is a life support technology that uses an artificial lung outside of the body to do the lung's work. ASCEND has two objectives. The first objective is to learn more about children's abilities and quality of life among ECMO-supported children in the year after they leave the pediatric intensive care unit. The second objective is to compare short and long-term patient outcomes in two groups of children: one group managed with a mechanical ventilation protocol that reserves the use of extracorporeal membrane oxygenation (ECMO) until protocol failure to another group supported on ECMO per usual care.
Los Angeles, California and other locations
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Sorry, not currently recruiting here
The goal of this interventional study is to compare standard mechanical ventilation to a lung-stress oriented ventilation strategy in patients with Acute Respiratory Distress Syndrome (ARDS). Participants will be ventilated according to one of two different strategies. The main question the study hopes to answer is whether the personalized ventilation strategy helps improve survival.
Los Angeles, California and other locations
Our lead scientists for Acute Respiratory Distress Syndrome research studies include Steven Y. Chang, MD, PhD.
Last updated: